09/05/2024 8:30 PM | Cline Christopher R. (Reporting) Travere Therapeutics, Inc. (Issuer) Travere Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 4:24 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form S-3ASR | |
08/01/2024 3:40 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 3:46 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:05 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 3:35 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form ARS | |
03/27/2024 3:31 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form DEF 14A | |
|
03/27/2024 3:31 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024 3:33 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer) Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form DEFA14A | |
02/20/2024 7:10 AM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 1:35 PM | ARMISTICE CAPITAL, LLC (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 5:38 AM | MACQUARIE GROUP LTD (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 9:33 AM | MORGAN STANLEY (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G | |
02/07/2024 6:37 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G/A | |
02/01/2024 8:57 PM | Dube Eric M (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 8:58 PM | Heerma Peter (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 8:58 PM | REED ELIZABETH E (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 8:58 PM | ROTE WILLIAM E. (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 11:44 AM | Dube Eric M (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 10:39 AM | REED ELIZABETH E (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 8:52 AM | ROTE WILLIAM E. (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/25/2024 8:24 AM | STATE STREET CORP (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024 12:17 PM | Dube Eric M (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 9:51 AM | ROTE WILLIAM E. (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 9:52 AM | REED ELIZABETH E (Reporting) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 6:07 AM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 3:11 PM | Inrig Jula (Reporting) Travere Therapeutics, Inc. (Issuer) Travere Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 4:14 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/06/2023 1:34 PM | BlackRock Inc. (Filed by) Travere Therapeutics, Inc. (Subject) Travere Therapeutics (Subject)
| Form SC 13G/A | |
09/21/2023 6:35 AM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/21/2023 6:35 AM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 4:00 PM | Travere Therapeutics, Inc. (Filer) Travere Therapeutics (Filer)
| Form 8-K/A | |